Error: Could not add to watchlist. X
+ Watchlist

Tekla Life Sciences Investors

XHQLX:US
NASDAQ GM
21.50
USD
0.04
0.19%
As of 9:29 AM EDT 9/22/2017
Fund Type
Closed-End Fund
52Wk Range
17.51 - 21.99
1 Yr Return
14.43%
YTD Return
25.96%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
21.54
52Wk Range
17.51 - 21.99
1 Yr Return
13.70%
YTD Return
25.96%
Fund Type
Closed-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 09/22/2017)
21.5
Total Assets (m USD) (on 09/22/2017)
459.246
Inception Date
05/08/1992
Last Dividend (on 08/24/2017)
0.42
Dividend Indicated Gross Yield
7.81%
Fund Managers
DANIEL R OMSTEAD "DAN"
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.00%
Current Mgmt Fee
1.05%
Expense Ratio
1.32%

Top Fund Holdings

Name Position Value % of Fund
116.96 k 31.98 m 7.37
443.12 k 30.10 m 6.94
241.53 k 30.05 m 6.93
180.08 k 29.55 m 6.81
195.82 k 26.18 m 6.04
54.63 k 21.17 m 4.88
191.38 k 20.93 m 4.83
159.70 k 19.36 m 4.47
73.26 k 12.50 m 2.88
142.10 k 12.47 m 2.88
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
Address
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
Phone
1-617-772-8500